K

Knight Therapeutics Inc
TSX:GUD

Watchlist Manager
Knight Therapeutics Inc
TSX:GUD
Watchlist
Price: 6.03 CAD 1.86% Market Closed
Market Cap: 598.7m CAD

Intrinsic Value

The intrinsic value of one GUD stock under the Base Case scenario is hidden CAD. Compared to the current market price of 6.03 CAD, Knight Therapeutics Inc is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

GUD Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Knight Therapeutics Inc

Intrinsic Value History
Dive into the past to invest in the future

GUD looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether GUD usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about GUD?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is GUD valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Knight Therapeutics Inc.

Explain Valuation
Compare GUD to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about GUD?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Knight Therapeutics Inc

Current Assets 400.7m
Cash & Short-Term Investments 118.1m
Receivables 130.1m
Other Current Assets 152.4m
Non-Current Assets 647.9m
Long-Term Investments 71.9m
PP&E 21.8m
Intangibles 469.7m
Other Non-Current Assets 84.5m
Current Liabilities 152.7m
Accounts Payable 112.9m
Other Current Liabilities 39.8m
Non-Current Liabilities 129.1m
Long-Term Debt 84.7m
Other Non-Current Liabilities 44.4m
Efficiency

Free Cash Flow Analysis
Knight Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Knight Therapeutics Inc

Revenue
413.8m CAD
Cost of Revenue
-238m CAD
Gross Profit
175.9m CAD
Operating Expenses
-187.4m CAD
Operating Income
-11.5m CAD
Other Expenses
8m CAD
Net Income
-3.5m CAD
Fundamental Scores

GUD Profitability Score
Profitability Due Diligence

Knight Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Healthy Gross Margin
Sustainable 3Y Average Gross Margin
Operating Margin is Increasing
ROE is Increasing
hidden
Profitability
Score

Knight Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

GUD Solvency Score
Solvency Due Diligence

Knight Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Low D/E
Short-Term Solvency
Negative Net Debt
hidden
Solvency
Score

Knight Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

GUD Price Targets Summary
Knight Therapeutics Inc

Wall Street analysts forecast GUD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GUD is 8.03 CAD with a low forecast of 6.21 CAD and a high forecast of 10.5 CAD.

Lowest
Price Target
6.21 CAD
3% Upside
Average
Price Target
8.03 CAD
33% Upside
Highest
Price Target
10.5 CAD
74% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Knight Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for GUD is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one GUD stock?

The intrinsic value of one GUD stock under the Base Case scenario is hidden CAD.

Is GUD stock undervalued or overvalued?

Compared to the current market price of 6.03 CAD, Knight Therapeutics Inc is hidden .

Back to Top